ArticleOral and maxillofacial surgery2026
Implementation of ultrasound surveillance following negative sentinel lymph node biopsy in early oral squamous cell carcinoma: a retrospective cohort study.
Article in Oral and maxillofacial surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeManagement of the clinically node-negative neck in T1/T2 oral squamous cell carcinoma (OSCC) is controversial. While sentinel lymph node biopsy (SLNB) can highlight patients that require selective neck dissection (SND); its false-negative rate necessitates post-operative surveillance to detect missed cervical lymph node metastases (CLNM) and allow for salvage surgery. Ultrasound (US) in conjunction with clinical examination is commonly employed for this observation; however, the optimal regimen is unclear. This retrospective cohort study aimed to evaluate follow-up surveillance after negative SLNB in patients with T1/T2 OSCC at our centre.
methodsFifty-eight patients were identified over eight years. Nine (15.5%) had a positive SLNB and underwent further treatment. In the remaining 49 patients, data was collected on US utilisation, timing, and outcome events. The primary outcome was CLNM identified by US examination.
resultsA total of 51 US examinations were performed. The median time to first US was 7 months (range 2-48; n = 29), second 16.5 months (range 8-50; n = 14), third 26 months (range 14-65; n = 7) and fourth 26 months (n = 1), demonstrating considerable deviation from the local protocol. No CLNM was identified by US surveillance following negative SLNB. Three patients (3/49, 6.1%) had events during follow-up. Two developed metachronous primary tumours and one developed multiple synchronous tumours.
conclusionUS surveillance following SLNB is variably implemented at our centre. These findings highlight the need for better defined and evidence-based protocols in this patient cohort.
Indexed as
Identifiers
42848233What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.